Antiseizure Medications in Development: Novel Mechanisms, Precision Therapy, and the Move Towards Disease Modification. [PDF]
Martins WA.
europepmc +1 more source
Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026. [PDF]
Morimoto S +3 more
europepmc +1 more source
Amitriptyline use in individuals with KCNQ2/3 gain-of-function variants: A retrospective cohort study. [PDF]
De Wachter M +18 more
europepmc +1 more source
KCNQ4 c.546C>G variant is associated with early-onset high-frequency hearing loss, tinnitus, and cardiovascular comorbidities in Taiwanese adults. [PDF]
Wu KL +5 more
europepmc +1 more source
Probing biomarkers and clinical utility of reward learning across species using the Probabilistic Reward Task: 20 years of findings. [PDF]
Pizzagalli DA.
europepmc +1 more source
A novel medication approach to treating obstructive sleep apnoea. [PDF]
Burgess K.
europepmc +1 more source
Editorial: Direct modulation of ion channels by G-proteins. [PDF]
Yakubovich D.
europepmc +1 more source
Differences in the Effectiveness of Uridine and <i>Liriope platyphylla</i> L. Between Complement Component 3 Deficiency- and Loperamide-Induced Constipation May Be Associated with the Alternative Regulation of the Cyclic Adenosine Monophosphate Downstream Signaling Pathway. [PDF]
Song HJ +11 more
europepmc +1 more source
A novel variant c.902C>A (p. A301D) in KCNQ4 associated with non-syndromic deafness 2A in a Chinese family. [PDF]
Ren L +7 more
europepmc +1 more source

